QLGN News and Press, Qualigen Therapeutics Inc. From 11/23/21

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...

Pasithea Therapeutics (NASDAQ:KTTA) +172% adds Esketamine nasal spray to its clinic offerings in the U.K. Petros Pharmaceuticals (NASDAQ:PTPI) +99%. iSpecimen ISPC +99% is set to extend rally after contract win for COVID-19 research Qualigen Therapeutics (NASDAQ:QLGN) +72%. Aad...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We’re getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday. Source: Shutterstock News moving stocks early this morning include earnin...

3 Penny Stocks to Add to Your Watchlist in Late-November With the short trading week for penny stocks and blue chips coming to an end, investors continue to search for the best small caps to buy. Today on November 22nd, we witnessed a sizable amount of market momentum that resulted in s...

Qualigen Therapeutics (NASDAQ:QLGN): Q3 GAAP EPS of -$0.10 beats by $0.11. Revenue of $1.16M (+38.1% Y/Y) misses by $0.18M. Press Release For further details see: Qualigen Therapeutics EPS beats by $0.11, misses on revenue

Quarterly r evenues i ncreased 38 % to approximately $1. 2 million , compared to approximately $ 0. 8 million in the same quarter of the previous year Year-to-date r evenues increased 30 % to...

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announces the publication of a study in the peer-reviewe...

Biomerica (NASDAQ:BMRA) +38% Walmart now selling Biomerica’s EZ Detect™ colorectal screening test Atea Pharmaceuticals (NASDAQ:AVIR) +29%. TDH Holdings (NASDAQ:PETZ) +17%. Progenity (NASDAQ:PROG) +25%. Bitfarms (NASDAQ:BITF) +14% amid equity weakness, El Salvador minin...

CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will pr...

CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will pr...